바이오인

바이오제품 시장 및 바이오기술개발 동향

- 바이오 산업원천기술개발사업 -

목 차

제1장 의약 바이오부문의 제품 시장 및 기술개발 동향 ·························· 17

제1절 단백질의약품 ··················································································································17
  1. 정의 및 범위·························································································································17
  2. 산업 동향·······························································································································19
  3. 기술 동향 및 기술개발 지원 현황···················································································36
  4. SWOT 분석···························································································································46

제2절 항체의약품 ······················································································································47
  1. 정의 및 범위·························································································································47
  2. 산업 동향·······························································································································50
  3. 기술 동향 및 기술개발 지원 현황···················································································59
  4. SWOT 분석···························································································································67

제3절 백 신 ·······························································································································68
  1. 정의 및 범위·························································································································68
  2. 산업 동향·······························································································································73
  3. 기술 동향 및 기술개발 지원 현황···················································································82
  4. SWOT 분석···························································································································93

제4절 유전자의약품 ··················································································································94
  1. 정의 및 범위·························································································································94
  2. 산업 동향·······························································································································99
  3. 기술 동향 및 기술개발 지원 현황·················································································113
  4. SWOT 분석·························································································································122

제5절 재생의약품 ····················································································································123
  1. 정의 및 범위·······················································································································123
  2. 산업 동향·····························································································································128
  3. 기술 동향 및 기술개발 지원 현황·················································································136
  4. SWOT 분석·························································································································143

제6절 약물전달시스템 ············································································································144
  1. 정의 및 범위·······················································································································144
  2. 산업 동향·····························································································································149
  3. 기술 동향 및 기술개발 지원 현황·················································································157
  4. SWOT 분석·························································································································170

제7절 저분자의약품 ················································································································172
  1. 정의 및 범위·······················································································································172
  2. 산업 동향·····························································································································175
  3. 기술 동향 및 기술개발 지원 현황·················································································192
  4. SWOT 분석·························································································································199

제8절 천연물의약품 ················································································································200
  1. 정의 및 범위·······················································································································200
  2. 산업 동향·····························································································································203
  3. 기술 동향 및 기술개발 지원 현황·················································································218
  4. SWOT 분석·························································································································231

제2장 산업 바이오부문의 제품 시장 및 기술개발 동향 ·························233

제1절 C2 계열 바이오리파이너리 ······················································································233
  1. 정의 및 범위·······················································································································233
  2. 산업 동향·····························································································································234
  3. 기술 동향 및 기술개발 지원 현황·················································································250
  4. SWOT 분석·························································································································263

제2절 C3 계열 바이오리파이너리 ······················································································264
  1. 정의 및 범위·······················································································································264
  2. 산업 동향·····························································································································267
  3. 기술 동향 및 기술개발 지원 현황·················································································281
  4. SWOT 분석·························································································································291

제3절 C4 계열 바이오리파이너리 ······················································································292
  1. 정의 및 범위·······················································································································292

  2. 산업 동향·····························································································································309
  3. 기술 동향 및 기술개발 지원 현황·················································································319
  4. SWOT 분석·························································································································332

제4절 바이오플라스틱 ············································································································333
  1. 정의 및 범위·······················································································································333
  2. 산업 동향·····························································································································336
  3. 기술 동향 및 기술개발 지원 현황·················································································351
  4. SWOT 분석·························································································································365

제5절 효 소 ·····························································································································366
  1. 정의 및 범위·······················································································································366
  2. 산업 동향·····························································································································367
  3. 기술 동향 및 기술개발 지원 현황·················································································383
  4. SWOT 분석·························································································································394

제6절 바이오소재 ····················································································································395

A. 식품소재·······························································································································395
  1. 정의 및 범위·······················································································································395
  2. 산업 동향·····························································································································396
  3. 기술 동향 및 기술개발 지원 현황·················································································411
  4. SWOT 분석·························································································································416

B. 화장품소재····························································································································417
  1. 정의 및 범위·······················································································································417
  2. 산업 동향·····························································································································420
  3. 기술 동향 및 기술개발 지원 현황·················································································426
  4. SWOT 분석·························································································································434

제3장 융합 바이오부문의 제품 시장 및 기술개발 동향 ·························436

제1절 바이오칩 ························································································································436
  1. 정의 및 범위·······················································································································436
  2. 산업 동향·····························································································································440
  3. 기술 동향 및 기술개발 지원 현황·················································································458

  4. SWOT 분석·························································································································469

제2절 랩온어칩 ························································································································471
  1. 정의 및 범위·······················································································································471
  2. 산업 동향·····························································································································476
  3. 기술 동향 및 기술개발 지원 현황·················································································485
  4. SWOT 분석·························································································································497

제3절 바이오장비 ····················································································································499
  1. 정의 및 범위·······················································································································499
  2. 산업 동향·····························································································································501
  3. 기술 동향 및 기술개발 지원 현황·················································································529
  4. SWOT 분석·························································································································545

제4장 그린 및 해양 바이오부문의 제품 시장 및 기술개발 동향 ········ 546

제1절 바이오농약 ····················································································································546
  1. 정의 및 범위·······················································································································546
  2. 산업 동향·····························································································································549
  3. 기술 동향 및 기술개발 지원 현황·················································································559
  4. SWOT 분석·························································································································568

제2절 해양 바이오 ··················································································································569
  1. 정의 및 범위·······················································································································569
  2. 산업 동향·····························································································································574
  3. 기술 동향 및 기술개발 지원 현황·················································································584
  4. SWOT 분석·························································································································603

☞ 자세한 내용은 내용바로가기의 첨부파일을 이용하시기 바랍니다.